Picture of Hikma Pharmaceuticals logo

HIK Hikma Pharmaceuticals News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

REG - Hikma Pharmaceutical - Holding(s) in Company




 



RNS Number : 6889E
Hikma Pharmaceuticals Plc
09 November 2020
 

TR-1: Standard form for notification of major holdings

 

LONDON, 9 November 2020 - Hikma Pharmaceuticals PLC (LEI:549300BNS685UXH4JI75) (LSE: HIK) (NasdaqDubai: HIK) (LSE: HIK) announces as follows:


NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)


1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Hikma Pharmaceuticals PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer


2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments


An event changing the breakdown of voting rights


Other (please specify):


3. Details of person subject to the notification obligation

Name

Wellington Management Group LLP

City and country of registered office (if applicable)

Boston, USA

4. Full name of shareholder(s)  (if different from 3)

Name

Bank of New York (Nominees) Ltd

BBH ISL NOMINEES LTD

BNY (OCS) Nominees Limited

GOLDMAN SACHS INTERNATIONAL

HSBC Global Custody Nominee (UK) Limited

Japan Trustee Services Bank Ltd.

JP Morgan Chase Nominees Limited

Mellon Nominees (UK) Ltd.

Nortrust Nominees Limited

ROY Nominees Limited

State Street Nominees Limited

VIDACOS NOMINEES LIMITED

City and country of registered office (if applicable)


5. Date on which the threshold was crossed or reached:

05/11/2020

6. Date on which issuer notified (DD/MM/YYYY):

06/11/2020

7. Total positions of person(s) subject to the notification obligation:


% of voting rights attached to shares

(total of 8.A)

% of voting rights through financial instruments

(total of 8.B.1 + 8.B.2)

Total of both in %

(8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

5.00%

0.01%

5.01%

230,496,614

Position of previous notification (if applicable)





 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached:

A: Voting rights attached to shares

Class/type of shares ISIN code (if possible)

Number of voting rights

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00B0LCW083 Common Stock


11,522,905


5.00%






SUBTOTAL 8.A

11,522,905

5.00%


B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights








SUBTOTAL 8.B.1




B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Physical or cash settlement

Number of voting rights

% of voting rights

Equity Swap

22/05/2023

08/10/2018to22/05/2023

Cash settlement

6,615 Equity Swap shares or 6,615 votes on a converted basis

0.00%

Equity Swap

15/05/2023

02/03/2018to15/05/2023

Cash settlement

4,378 Equity Swap shares or 4,378 votes on a converted basis

0.00%

Equity Swap

15/05/2023

10/10/2017to15/05/2023

Cash settlement

4,019 Equity Swap shares or 4,019 votes on a converted basis

0.00%

Equity Swap

22/05/2023

05/10/2018to22/05/2023

Cash settlement

1,931 Equity Swap shares or 1,931 votes on a converted basis

0.00%

Equity Swap

15/05/2023

16/07/2018to15/05/2023

Cash settlement

1,455 Equity Swap shares or 1,455 votes on a converted basis

0.00%

Equity Swap

15/05/2023

02/02/2018to15/05/2023

Cash settlement

1,450 Equity Swap shares or 1,450 votes on a converted basis

0.00%

Equity Swap

22/05/2023

08/01/2019to22/05/2023

Cash settlement

1,434 Equity Swap shares or 1,434 votes on a converted basis

0.00%

Equity Swap

15/05/2023

02/07/2018to15/05/2023

Cash settlement

1,376 Equity Swap shares or 1,376 votes on a converted basis

0.00%

Equity Swap

22/05/2023

03/07/2018to22/05/2023

Cash settlement

1,317 Equity Swap shares or 1,317 votes on a converted basis

0.00%

Equity Swap

15/05/2023

23/10/2017to15/05/2023

Cash settlement

1,156 Equity Swap shares or 1,156 votes on a converted basis

0.00%

Equity Swap

15/05/2023

11/06/2018to15/05/2023

Cash settlement

1,138 Equity Swap shares or 1,138 votes on a converted basis

0.00%

Equity Swap

22/05/2023

15/07/2019to22/05/2023

Cash settlement

1,134 Equity Swap shares or 1,134 votes on a converted basis

0.00%

Equity Swap

22/05/2023

05/04/2018to22/05/2023

Cash settlement

1,124 Equity Swap shares or 1,124 votes on a converted basis

0.00%

Equity Swap

05/05/2023

10/09/2020to05/05/2023

Cash settlement

956 Equity Swap shares or 956 votes on a converted basis

0.00%

Equity Swap

05/05/2023

11/09/2020to05/05/2023

Cash settlement

871 Equity Swap shares or 871 votes on a converted basis

0.00%

Index Future

05/11/2020

01/01/1900to05/11/2020

Cash settlement

1,289 Index Future shares or 840 votes on a converted basis

0.00%

Equity Swap

15/05/2023

27/07/2018to15/05/2023

Cash settlement

709 Equity Swap shares or 709 votes on a converted basis

0.00%

Equity Swap

15/05/2023

26/03/2018to15/05/2023

Cash settlement

517 Equity Swap shares or 517 votes on a converted basis

0.00%

Equity Swap

15/05/2023

16/04/2018to15/05/2023

Cash settlement

445 Equity Swap shares or 445 votes on a converted basis

0.00%

Equity Swap

05/05/2023

30/07/2018to05/05/2023

Cash settlement

291 Equity Swap shares or 291 votes on a converted basis

0.00%

Equity Swap

05/05/2023

24/09/2020to05/05/2023

Cash settlement

249 Equity Swap shares or 249 votes on a converted basis

0.00%

Equity Swap

05/05/2023

24/09/2020to05/05/2023

Cash settlement

197 Equity Swap shares or 197 votes on a converted basis

0.00%

Equity Swap

05/05/2023

09/09/2020to05/05/2023

Cash settlement

193 Equity Swap shares or 193 votes on a converted basis

0.00%

Equity Swap

15/05/2023

18/06/2018to15/05/2023

Cash settlement

177 Equity Swap shares or 177 votes on a converted basis

0.00%

Equity Swap

05/05/2023

24/09/2020to05/05/2023

Cash settlement

5 Equity Swap shares or 5 votes on a converted basis

0.00%










SUBTOTAL 8.B.2

33,977

0.01%

 

 

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.


Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)

X

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Wellington Management Group LLP



5.01%

Wellington Group Holdings LLP



5.01%

Wellington Investment Advisors Holdings LLP



5.01%

Wellington Management Company LLP








Wellington Management Group LLP



5.01%

Wellington Group Holdings LLP



5.01%

Wellington Investment Advisors Holdings LLP



5.01%

Wellington Management Global Holdings, Ltd.




Wellington Management International Ltd










10. In case of proxy voting, please identify:

Name of the proxy holder


The number and % of voting rights held


The date until which the voting rights will be held



11. Additional information:

 


 


Place of completion

Boston, MA USA

Date of completion

06/11/2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUKOARRVUARAA

Recent news on Hikma Pharmaceuticals

See all news